Market Tracker

05/22 5:16pm ET

Immunomedics Inc (NASDAQ:IMMU)

4.10
Delayed Data
As of May 22
 +0.02 / +0.49%
Today’s Change
3.08
Today|||52-Week Range
5.48
-14.58%
Year-to-Date

Today’s Trading

Previous close4.08
Today’s open4.05
Day’s range3.98 - 4.12
Volume848,740
Average volume (3 months)828,005
Market cap$383.2M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-18.25%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book9.70

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd+0.27+2.27%
ENTLEntellus Medical Inc-0.56-2.34%
ARAYAccuray Inc+0.02+0.33%
CUTRCutera Inc-0.15-1.03%
Data as of 4:14pm ET, 05/22/2015

Financials

Next reporting dateAugust 20, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts